Raunak Shrestha

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Supplementary Figure 6 from Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

  2026-06-17

• Supplementary Figure 3 from Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

  2026-06-17

• Supplementary Figure 5 from Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

  2026-06-17

• Supplementary Figure 2 from Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

  2026-06-17

• Supplementary Figure 7 from Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

  2026-06-17

• Supplementary Figure 4 from Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

  2026-06-17

• Supplementary Figure 1 from Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

  2026-06-17

• Morphogenetic Neural Plasticity for Adaptive Robotic SystemsPreprint

  Research Square · 2026-04-21

• Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer

  Genome biology · 2026-04-15

• Non-invasive prostate cancer subtyping using 5hmC-sequencing of cell-free DNA.

  Journal of Clinical Oncology · 2026-03-01

• Epigenomic alterations associated with androgen receptor pathway inhibitor response in metastatic castration-resistant prostate cancer.

  Journal of Clinical Oncology · 2026-03-01

• Abstract A011: Interplay of AR co-activators, CBP/p300, and immune regulation in prostate cancer

  Cancer Research · 2026-01-20

• Supplementary Figure 4. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

  2025-11-24

• Supplementary Figure 8. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

  2025-11-24

• Supplementary Figure 7. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

  2025-11-24

• Supplementary Figure 5. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

  2025-11-24

• Supplementary Table 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

  2025-11-24

• Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

  2025-11-24

• Supplementary Figure 6. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

  2025-11-24

• Supplementary Data 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

  2025-11-24